𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of Antiphospholipid Antibodies in Nephropathies Not Due to Systemic Lupus Erythematosus

✍ Scribed by Quereda, C.; Garcia Otero, G.; Pardo, A.; Orte, L.; Rivera, M.; Gonzalo, A.; Pascual, J.; Ortuño, J.

Book ID
124147370
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
680 KB
Volume
23
Category
Article
ISSN
0272-6386

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiphospholipid syndrome nephropathy in
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long-term outcome
✍ Maria G. Tektonidou; Flora Sotsiou; Lidia Nakopoulou; Panayiotis G. Vlachoyianno 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

## Abstract ## Objective To evaluate the prevalence, clinical associations, and outcome of antiphospholipid syndrome (APS) nephropathy in patients with systemic lupus erythematosus (SLE) and antiphospholipid antibodies (aPL) and in SLE patients without aPL. ## Methods Kidney biopsy specimens obt

Relationship of antiphospholipid antibod
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus
✍ Afshin Farzaneh-Far; Mary J. Roman; Michael D. Lockshin; Richard B. Devereux; St 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

## Abstract ## Objective Although antiphospholipid antibodies (aPL) are associated with arterial and venous thrombosis in systemic lupus erythematosus (SLE), the extent to which they influence other cardiovascular manifestations is either controversial or uncertain. We undertook this study to exam

The prevalence, onset, and clinical sign
The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus
✍ Micah T. McClain; Melissa R. Arbuckle; Latisha D. Heinlen; Gregory J. Dennis; Jo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Objective: To determine whether antiphospholipid antibodies (apl) occur before the diagnosis of systemic lupus erythematosus (sle) and before initial clotting events, and whether their presence early in the disease course influences clinical outcome. ## Methods: Serum samples obtained from 130